genken's Highlights on 'The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound | Journal of Experimental Medicine | Rockefeller University Press' | Glasp